企業プロフィール

HOOKIPA Pharma Inc. 株価・ニュース・カタリスト

ティッカー:: HOOK
取引所:: NASDAQ
セクター:: Biopharma
所在地:: United States

株価パフォーマンス

1.15 USD (+0.88%)

終値

最終更新: 2026年6月2日

—

時価総額

株価変動の要因

Current closing-price context is not available for HOOK.

企業概要

事業概要

Hookipa Pharma is a biopharmaceutical company focused on immunotherapy and oncology, with a strategy that has centered on viral-vector and immune-based platforms. Its business has been shaped by platform ambition and strategic resets.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ, Hookipa sits in specialty biotechnology.

ビジネスモデルの特徴

The company depends on clinical validation, partnerships, and the ability to find a durable immune-therapy franchise.

バイオ業界での位置付け

Hookipa is a high-risk immunology name whose story depends heavily on platform and financing progress.

今後のカタリスト

HOOKIPA’s catalysts are HB-700 and the rest of its viro-immunotherapy platform, plus any partnership or strategic update. The market will care about whether the viral-immunotherapy thesis still has a path.